Discover more insights into Antibody Dependent Enhancement 항체 의존적 증강

Keywords frequently search together with Antibody Dependent Enhancement 항체 의존적 증강

Narrow sentence examples with built-in keyword filters

Antibody Dependent Enhancement sentence examples within neutralizing antibodies without

Conjugation of Hemoglobin and Mannan Markedly Improves the Immunogenicity of Domain III of the Zika Virus E Protein: Structural and Immunological Study.

Recombinant vaccine containing an RBD-Fc fusion induced protection against SARS-CoV-2 in nonhuman primates and mice

Previous exposure to dengue virus is associated with increased Zika virus burden at the maternal-fetal interface in rhesus macaques

Modeling Dengue Immune Responses Mediated by Antibodies: a Qualitative Study

Multisystem Inflammatory Syndrome in Children Associated with COVID-19: An Interim Review

A mRNA-LNP vaccine against Dengue Virus elicits robust, serotype-specific immunity

One Medicine: a comparative approach to investigating human and animal coronavirus infections

Ophthalmological Considerations for COVID-19 Vaccination in Patients with Inflammatory Eye Diseases and Autoimmune Disorders

Persistence of Human Bocavirus 1 in Tonsillar Germinal Centers and Antibody-Dependent Enhancement of Infection

Antibody Response against SARS-CoV-2 and Seasonal Coronaviruses in Nonhospitalized COVID-19 Patients

The impact of COVID-19 vaccination campaigns accounting for antibody-dependent enhancement

Glycan reactive anti-HIV-1 antibodies bind the SARS-CoV-2 spike protein but do not block viral entry

Congenital abnormalities associated with Zika virus infection–Dengue as potential co-factor? A systematic review

A therapeutic neutralizing antibody targeting receptor binding domain of SARS-CoV-2 spike protein

The impact of COVID-19 vaccination campaigns accounting for antibody-dependent enhancement

Characterization of MW06, a human monoclonal antibody with cross-neutralization activity against both SARS-CoV-2 and SARS-CoV

Antibody-Dependent Enhancement and the Critical Pattern of COVID-19: Possibilities and Considerations.

Antibody-Dependent Enhancement of SARS-CoV-2 Infection Is Mediated by the IgG Receptors FcγRIIA and FcγRIIIA but Does Not Contribute to Aberrant Cytokine Production by Macrophages

A Novel SARS-CoV-2 Multitope Protein/Peptide Vaccine Candidate is Highly Immunogenic and Prevents Lung Infection in an AAV hACE2 Mouse Model and non-human primates

Prior dengue immunity enhances Zika virus infection of the maternal-fetal interface in rhesus macaques

An affinity-matured human monoclonal antibody targeting fusion loop epitope of dengue virus with in vivo therapeutic potency

Enhanced dengue vaccine virus replication and neutralizing antibody responses in immune primed rhesus macaques

Symptomatic similarity, co-infection and cross-reactivity in dengue and Covid-19 disease

Non-neutralizing SARS CoV-2 directed polyclonal antibodies demonstrate cross-reactivity with the HA glycans of influenza virus

Pathogenesis of Coronaviruses Through Human Monocytes and Tissue Macrophages.

A SARS-CoV-2 neutralizing antibody with extensive Spike binding coverage and modified for optimal therapeutic outcomes

A proof of concept for neutralizing antibody-guided vaccine design against SARS-CoV-2

The Current Status and Challenges in the Development of Vaccines and Drugs against Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-CoV-2)

Antibody-Dependent Enhancement (ADE) of SARS-CoV-2 Infection Requires FcγRIIB and Virus-Antibody Complex With Bivalent Interaction

Structure-Based Virtual Screening: Identification of a Novel NS2B-NS3 Protease Inhibitor with Potent Antiviral Activity against Zika and Dengue Viruses

Gastrointestinal and hepatic diseases during the COVID-19 pandemic: Manifestations, mechanism and management

Efficacy of a live attenuated highly pathogenic PRRSV vaccine against a NADC30-like strain challenge: implications for ADE of PRRSV

SARS-CoV-2 Infection and Antibody-Dependent Enhancement

Characterization of SARS-CoV-2-specific humoral immunity and its potential applications and therapeutic prospects

Ceftazidime is a potential drug to inhibit SARS-CoV-2 infection in vitro by blocking spike protein–ACE2 interaction

AI Aided Design of Epitope-Based Vaccine for the Induction of Cellular Immune Responses Against SARS-CoV-2

A review: Antibody-dependent enhancement in COVID-19: The not so friendly side of antibodies

No Evidence for Human Monocyte-Derived Macrophage Infection and Antibody-Mediated Enhancement of SARS-CoV-2 Infection

The COVID-19 vaccine development: A pandemic paradigm

Novel Japanese encephalitis virus NS1-based vaccine: Truncated NS1 fused with E. coli heat labile enterotoxin B subunit

The preparation of N-IgY targeting SARS-CoV-2 and its immunomodulation to IFN-γ production in vitro

Protective Zika vaccines engineered to eliminate enhancement of dengue infection via immunodominance switch.

Dengue Virus and Vaccines: How Can DNA Immunization Contribute to This Challenge?

mRNA vaccine: a potential therapeutic strategy

Enhancement versus neutralization by SARS-CoV-2 antibodies from a convalescent donor associates with distinct epitopes on the RBD

Anti-SARS-CoV-2 IgG and IgA antibodies in COVID-19 convalescent plasma do not facilitate antibody-dependent enhance of viral infection.

The signal pathways and treatment of cytokine storm in COVID-19

Human single-chain antibodies neutralize SARS-CoV-2 variants by engaging an essential epitope of the spike: a new weapon against COVID-19

Monomeric IgA antagonizes IgG-mediated enhancement of DENV infection

[Research progress on antibody-dependent enhancement in infectious diseases].

Current development of Zika virus vaccines with special emphasis on virus-like particle technology.

Dynamics of host immune responses to SARS-CoV-2

Amplificación de la infección dependiente de anticuerpos en la inmunopatogénesis del dengue grave, implicaciones para el desarrollo y uso de las vacunas

Targeted Antibody Blocking by a Dual-Functional Conjugate of Antigenic Peptide and Fc-III Mimetics (DCAF).

Peptide-Based Subunit Vaccine Design of T- and B-Cells Multi-Epitopes against Zika Virus Using Immunoinformatics Approaches

System of delay differential equations with application in dengue fever

Tick-borne encephalitis virus vaccination breakthrough infections in Germany - A retrospective analysis from 2001-2018.

Learn more from Antibody Dependent Enhancement 항체 의존적 증강

Antibody Dependent Enhancement 항체 의존적 증강

Antibody Dependent Enhancement 항체 의존적 증강
Encyclopedia 백과사전